CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$10.26
+15.95%
Mkt Cap $509.46M
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (19 analysts)
$28.00
Range $17.00 – $40.00
Implied Upside
+173.0%
Consensus $28.00 vs current $10.26
NASDAQ·Healthcare·Biotechnology
$10.26
+15.95%
Mkt Cap $509.46M
Buy
15
Hold
0
Sell
0
Price Target (19 analysts)
$28.00
Range $17.00 – $40.00
+173.0%
Consensus $28.00 vs current $10.26